GlassScriptPhysician profile
Paul D Mullin
NPI 1588682827
$150,635.94
in general payments reported to CMS, 2019-2025
40 companies · $438 in 2025
The $438 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102K · 2020: $13K · 2021: $20K · 2022: $13K · 2023: $1,288 · 2024: $619 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,136 · Education: $209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,136.14 |
| Education | $208.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aquestive Therapeutics, INC. | $141,561.83 | 2019-2022 | |
| Sk Life Science, INC. | $4,026.35 | 2020-2025 | |
| Lilly USA, LLC | $974.11 | 2019-2025 | Emgality, Kisunla, Amyvid |
| Teva Pharmaceuticals USA, INC. | $876.50 | 2020-2025 | Austedo Xr, Austedo |
| Eisai INC. | $450.51 | 2021-2025 | |
| Abbvie INC. | $402.30 | 2021-2025 | |
| Ucb, INC. | $361.55 | 2021-2023 | Briviact, Nayzilam |
| Livanova USA, INC. | $182.55 | 2024-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Greenwich Biosciences, INC. | $180.65 | 2019-2021 | |
| Neurelis, INC. | $149.99 | 2021-2024 | Valtoco |
| Argenx US, INC. | $135.96 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Harmony Biosciences LLC | $131.64 | 2021-2023 | Wakix |
| Amgen INC. | $110.77 | 2021-2023 | Evenity, Prolia |
| Neurocrine Biosciences, INC. | $103.95 | 2022-2023 | Ingrezza, Ongentys |
| Allergan, INC. | $89.78 | 2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Mullin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.